Hussein Khaled

3.1k total citations
47 papers, 748 citations indexed

About

Hussein Khaled is a scholar working on Surgery, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Hussein Khaled has authored 47 papers receiving a total of 748 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Surgery, 17 papers in Oncology and 16 papers in Pathology and Forensic Medicine. Recurrent topics in Hussein Khaled's work include Bladder and Urothelial Cancer Treatments (17 papers), Urinary and Genital Oncology Studies (12 papers) and Lymphoma Diagnosis and Treatment (10 papers). Hussein Khaled is often cited by papers focused on Bladder and Urothelial Cancer Treatments (17 papers), Urinary and Genital Oncology Studies (12 papers) and Lymphoma Diagnosis and Treatment (10 papers). Hussein Khaled collaborates with scholars based in Egypt, United States and France. Hussein Khaled's co-authors include Rabab Gaafar, Nicholas Pavlidis, Mohamed S. Zaghloul, Marwa I. Shabayek, John P. Christodouleas, Wei‐Ting Hwang, Brian C. Baumann, Andrew M. Smith, Christopher A. Loffredo and Nabiel Mikhail and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Urology.

In The Last Decade

Hussein Khaled

46 papers receiving 727 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hussein Khaled Egypt 17 313 258 196 165 164 47 748
M. Beer United States 15 175 0.6× 266 1.0× 101 0.5× 111 0.7× 99 0.6× 33 555
Andrew von Eschenbach United States 12 619 2.0× 526 2.0× 163 0.8× 417 2.5× 326 2.0× 20 1.3k
Kim Ørnvold United States 14 315 1.0× 148 0.6× 90 0.5× 170 1.0× 98 0.6× 37 737
Mauro Antimi Italy 10 303 1.0× 273 1.1× 51 0.3× 82 0.5× 157 1.0× 24 601
Martina Catalano Italy 16 200 0.6× 323 1.3× 61 0.3× 215 1.3× 270 1.6× 70 749
Giovanni Casetta Italy 17 427 1.4× 154 0.6× 56 0.3× 345 2.1× 152 0.9× 50 887
Isabelle Meiers United States 14 244 0.8× 70 0.3× 36 0.2× 233 1.4× 374 2.3× 30 797
Chiara Minacci Italy 12 238 0.8× 235 0.9× 318 1.6× 117 0.7× 169 1.0× 32 719
Elizabeth E. Frauenhoffer United States 14 135 0.4× 105 0.4× 152 0.8× 194 1.2× 117 0.7× 43 693
Muhammad Shurafa United States 12 89 0.3× 319 1.2× 142 0.7× 271 1.6× 69 0.4× 29 912

Countries citing papers authored by Hussein Khaled

Since Specialization
Citations

This map shows the geographic impact of Hussein Khaled's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hussein Khaled with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hussein Khaled more than expected).

Fields of papers citing papers by Hussein Khaled

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hussein Khaled. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hussein Khaled. The network helps show where Hussein Khaled may publish in the future.

Co-authorship network of co-authors of Hussein Khaled

This figure shows the co-authorship network connecting the top 25 collaborators of Hussein Khaled. A scholar is included among the top collaborators of Hussein Khaled based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hussein Khaled. Hussein Khaled is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ayache, Samar S., et al.. (2025). The effect of the EXOPULSE Mollii suit on motor functions in patients with multiple sclerosis – a randomized sham-controlled crossover trial. Multiple Sclerosis Journal - Experimental Translational and Clinical. 11(2). 3120711504–3120711504.
2.
Tombal, Bertrand, F. Gómez-Veiga, Á. Gómez-Ferrer, et al.. (2024). A Phase 2 Randomized Open-label Study of Oral Darolutamide Monotherapy Versus Androgen Deprivation Therapy in Men with Hormone-sensitive Prostate Cancer (EORTC-GUCG 1532). European Urology Oncology. 7(5). 1051–1060. 5 indexed citations
3.
Khaled, Hussein, et al.. (2023). Urinary BLACAT1 as a non-invasive biomarker for bladder cancer. Molecular Biology Reports. 50(5). 4339–4345. 3 indexed citations
4.
Tombal, Bertrand, F. Gómez-Veiga, Á. Gómez-Ferrer, et al.. (2023). A phase 2 randomized open-label study of oral darolutamide monotherapy vs. androgen deprivation therapy in men with hormone-naive prostate cancer (EORTC-GUCG 1532).. Journal of Clinical Oncology. 41(6_suppl). 160–160. 1 indexed citations
5.
Lotfy, Mai M., Mohamed Abouelhoda, Zeinab Hassan, et al.. (2022). Multigene Panel Sequencing Reveals Cancer-Specific and Common Somatic Mutations in Colorectal Cancer Patients: An Egyptian Experience. Current Issues in Molecular Biology. 44(3). 1332–1352. 8 indexed citations
6.
Shouman, Samia A., et al.. (2020). Capecitabine-Based Chemoendocrine Combination as First-Line Treatment for Metastatic Hormone-Positive Metastatic Breast Cancer: Phase 2 Study. Clinical Breast Cancer. 20(3). 228–237. 9 indexed citations
7.
8.
Khaled, Hussein, et al.. (2016). Review on renal cell carcinoma and pregnancy: A challenging situation. Journal of Advanced Research. 7(4). 575–580. 16 indexed citations
9.
Zekri, Abdel‐Rahman N., et al.. (2015). Differentially Expressed Genes in Metastatic Advanced Egyptian Bladder Cancer. Asian Pacific Journal of Cancer Prevention. 16(8). 3543–3549. 26 indexed citations
10.
Khaled, Hussein, et al.. (2015). A multicenter, phase II study of the RAF-kinase inhibitor sorafenib in patients with advanced renal cell carcinoma. Molecular and Clinical Oncology. 3(5). 1099–1102. 4 indexed citations
11.
Pavlidis, Nicholas, Hussein Khaled, & Rabab Gaafar. (2014). A mini review on cancer of unknown primary site: A clinical puzzle for the oncologists. Journal of Advanced Research. 6(3). 375–382. 77 indexed citations
12.
13.
Amr, Sania, Doa’a A. Saleh, Laurence S. Magder, et al.. (2013). Agricultural Workers and Urinary Bladder Cancer Risk in Egypt. Archives of Environmental & Occupational Health. 69(1). 3–10. 18 indexed citations
14.
15.
Khaled, Hussein, et al.. (2005). A prognostic index (bladder prognostic index) for bilharzial-related invasive bladder cancer. Urologic Oncology Seminars and Original Investigations. 23(4). 254–260. 16 indexed citations
16.
Khaled, Hussein, et al.. (2001). Bladder cancer in Africa: Update. Seminars in Oncology. 28(2). 174–178. 66 indexed citations
17.
Khaled, Hussein, et al.. (2001). Evaluation of the BTA Tests for the Detection of Bilharzial Related Bladder Cancer: The Cairo Experience. European Urology. 39(1). 91–94. 11 indexed citations
18.
Khaled, Hussein, et al.. (2000). A phase II study of gemcitabine plus cisplatin chemotherapy in advanced bilharzial bladder carcinoma. European Journal of Cancer. 36. 34–37. 23 indexed citations
19.
Khaled, Hussein, et al.. (1999). A randomized EPOCH vs. CHOP front-line therapy for aggressive non-Hodgkin's lymphoma patients: Long-term results. Annals of Oncology. 10(12). 1489–1492. 20 indexed citations
20.
Khaled, Hussein, et al.. (1990). Ifosfamide, methotrexate, and 5-fluorouracil: effective combination in resistant breast cancer. Cancer Chemotherapy and Pharmacology. 26(S1). S85–S86. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. Beer Breakdown of academic impact, for papers by Andrew von Eschenbach Breakdown of academic impact, for papers by Kim Ørnvold Breakdown of academic impact, for papers by Mauro Antimi Breakdown of academic impact, for papers by Martina Catalano Breakdown of academic impact, for papers by Giovanni Casetta Breakdown of academic impact, for papers by Isabelle Meiers Breakdown of academic impact, for papers by Chiara Minacci Breakdown of academic impact, for papers by Elizabeth E. Frauenhoffer Breakdown of academic impact, for papers by Muhammad Shurafa
Rankless by CCL
2026